MARKET

JAGX

JAGX

Jaguar Health
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6615
-0.0790
-10.67%
After Hours: 0.6800 +0.0185 +2.80% 18:10 11/15 EST
OPEN
0.7400
PREV CLOSE
0.7405
HIGH
0.7410
LOW
0.6500
VOLUME
975.10K
TURNOVER
--
52 WEEK HIGH
36.39
52 WEEK LOW
0.6410
MARKET CAP
27.29M
P/E (TTM)
-0.0001
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of JAGX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

JAGX News

  • IGT, OPRA, PING and SINA among midday movers
  • Seeking Alpha - Article.3d ago
  • Jaguar Health down 21% on Mytesi trial continuation
  • Seeking Alpha - Article.3d ago
  • Jaguar Health Q3 EPS $(2) Up From $(37.77) YoY, Sales $973K Down From $1.132M YoY
  • Benzinga.3d ago
  • Jaguar Health, Inc. Reports 2019 Third Quarter Financial Results
  • ACCESSWIRE.3d ago

More

Industry

Biotechnology & Medical Research
+1.25%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About JAGX

Jaguar Health, Inc., formerly Jaguar Animal Health, Inc., is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc., is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Its Mytesi is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with human immunodeficiency virus HIV/ acquired immune deficiency syndrome (AIDS) on antiretroviral therapy. Its other products include Canalevia, Equilevia, Neonorm Calf and Neonorm Foal.
More

Webull offers Jaguar Health Inc (JAGX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.